Application of modelling and nanotechnology‐based approaches: The emergence of breakthroughs in theranostics of central nervous system disorders

  title={Application of modelling and nanotechnology‐based approaches: The emergence of breakthroughs in theranostics of central nervous system disorders},
  author={Parichehr Hassanzadeh and Fatemeh Atyabi and Rassoul Dinarvand},
  journal={Life Sciences},

Figures from this paper

Nanoparticles reshape the biomedical industry
In neurology, high-resolution imaging techniques, nanoengineered materials capable of interaction with the nervous systems, and nanopharmaceuticals with minimal toxicity and improved bioavailability may be of great theranostic significance, which may provide remarkable breakthroughs in the pharmaceutical industry and health-care system.
Linkers: The key elements for the creation of efficient nanotherapeutics
Emerging vistas in theranostic medicine
Nanoparticle based gene therapy approach: A pioneering rebellion in the management of psychiatric disorders.
The present manuscript discusses the prospects of gene therapy in psychiatric disorders, their benefits, and pitfalls, and embarks upon the importance of nanoparticle-based gene therapy for an effective management of psychiatric disorders.
Nanotheranostics against COVID-19: From multivalent to immune-targeted materials
Nanotechnology in Improving the Treatment of Huntington's Disease: a Systematic Review.
Why nanotechnology could apply to improve the transport of drugs through BBB based on already postulated hypotheses about potential pharmacological therapy against some HD symptoms is presented.
Multi-disciplinary Approach for Drug and Gene Delivery Systems to the Brain
A broad overview of present-day strategies for brain drug delivery is provided, emphasizing novel delivery systems and novel non-nanoparticle strategies such as using viral and peptide vectors and other non-invasive techniques to enhance brain uptake of drugs.


Application of Carbon Nanotubes for Controlled Release of Growth Factors or Endocannabinoids: A Breakthrough in Biomedicine
Based on their unique properties, the appropriate application of functionalized CNTs may indeed revolutionize the current biomedical interventions that has been highlighted in the present review.
Nanotechnology—novel therapeutics for CNS disorders
Recent advances in the development of nanotechnology for the treatment of neurological disorders—in particular, neurodegenerative disease and malignant brain tumours—and for the promotion of neuroregeneration are described.
From Molecular to Nanotechnology Strategies for Delivery of Neurotrophins: Emphasis on Brain-Derived Neurotrophic Factor (BDNF)
Biomimetic peptides of BDNF have emerged as a promising therapy against neurodegenerative disorders and polymer-based carriers have provided sustained neurotrophin delivery, whereas lipid-based particles have contributed also to potentiation of the BDNF action.
Modeling the structure‐property relationships of nanoneedles: A journey toward nanomedicine
Due to the apolar characteristics of CNNs and their ability to carry ionic species, they would be suitable to act as drug carriers through nonpolar biologic media, and might act as semiconductors at the limit of infinite‐length.
Creation of Nanorobots: Both State-of-the-Science and State-of-the-Art
Development of the medical nanorobots with a wide range of capabilities is a proof of concept and art in modern science and a breakthrough in nanotechnology which has been highlighted in the present manuscript.
Magnetic nanoparticles for theragnostics.
Nanogels for oligonucleotide delivery to the brain.
It is demonstrated that as a result of incorporation into nanogel 1 h after intravenous injection the accumulation of a phosphorothioate ODN in the brain increases by over 15 fold while in liver and spleen decreases by 2-fold compared to the free ODN.
Magnetic Core–Shell Nanocapsules with Dual‐Targeting Capabilities and Co‐Delivery of Multiple Drugs to Treat Brain Gliomas
The results demonstrate that the dual (Dox+Cur)‐drug‐loaded nanocapsule can be effectively delivered into RG2 glioma cells to enhance the cytotoxicity against the cells through a synergistic effect.
Intrinsic targeting of inflammatory cells in the brain by polyamidoamine dendrimers upon subarachnoid administration.
This intrinsic ability of dendrimers to localize inactivated microglia and astrocytes can enable targeted delivery of therapeutics in disorders such as cerebral palsy, Alzheimer's and multiple sclerosis.